Correlation Between Nexalin Technology and Heart Test

Can any of the company-specific risk be diversified away by investing in both Nexalin Technology and Heart Test at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nexalin Technology and Heart Test into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nexalin Technology and Heart Test Laboratories, you can compare the effects of market volatilities on Nexalin Technology and Heart Test and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nexalin Technology with a short position of Heart Test. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nexalin Technology and Heart Test.

Diversification Opportunities for Nexalin Technology and Heart Test

-0.53

Correlation Coefficient

Nexalin Technology  Heart Test

Excellent diversification

The 3 months correlation between Nexalin and Heart is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Nexalin Technology and Heart Test Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heart Test Laboratories and Nexalin Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nexalin Technology are associated (or correlated) with Heart Test. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heart Test Laboratories has no effect on the direction of Nexalin Technology i.e., Nexalin Technology and Heart Test go up and down completely randomly.

Pair Corralation between Nexalin Technology and Heart Test

Considering the 90-day investment horizon Nexalin Technology is expected to generate 1.72 times more return on investment than Heart Test. However, Nexalin Technology is 1.72 times more volatile than Heart Test Laboratories. It trades about 0.11 of its potential returns per unit of risk. Heart Test Laboratories is currently generating about -0.02 per unit of risk. If you would invest  33.00  in Nexalin Technology on October 1, 2024 and sell it today you would earn a total of  262.00  from holding Nexalin Technology or generate 793.94% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Nexalin Technology  vs.  Heart Test Laboratories

Nexalin Technology

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Nexalin Technology are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite quite abnormal basic indicators, Nexalin Technology disclosed solid returns over the last few months and may actually be approaching a breakup point.

Heart Test Laboratories

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Heart Test Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Nexalin Technology and Heart Test

The main advantage of trading using opposite Nexalin Technology and Heart Test positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nexalin Technology position performs unexpectedly, Heart Test can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heart Test will offset losses from the drop in Heart Test's long position.

The idea behind Nexalin Technology and Heart Test Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.